[TRIALS OF A NEW ANTIHYPERTENSIVE,   ALPHA-METHYL-DOPA (ALDOMET) WITH SPECIAL REFERENCE TO CHANGES IN RETINAL BLOOD FLOW].
D000809:Angiotensins; D000959:Antihypertensive Agents; D001775:Blood Circulation; D001794:Blood Pressure; D001795:Blood Pressure Determination; D004298:Dopamine; D004837:Epinephrine; D006439:Hemodynamics; D008750:Methyldopa; D009243:NAD; D009638:Norepinephrine; D010649:Phenylalanine; D012083:Renin; D012171:Retinal Vessels; D012701:Serotonin; D014364:Tryptophan; D014443:Tyrosine
D000809:Angiotensins; D000959:Antihypertensive Agents; D009243:NAD; D012701:Serotonin; D014443:Tyrosine; D010649:Phenylalanine; D008750:Methyldopa; D014364:Tryptophan; D012083:Renin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
ANGIOTENSIN; ANTIHYPERTENSIVE AGENTS; BLOOD CIRCULATION; BLOOD PRESSURE; DOPAMINE; EPINEPHRINE; METHYLDOPA; NAD; NOREPINEPHRINE; PHENYLALANINE; RENIN; RETINAL VESSELS; SEROTONIN; TRYPTOPHAN; TYROSINE